Form 4: Beta Bionics Executive Granted Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Mark Hopman, Chief Commercial Officer of Beta Bionics, received 52,000 stock options and 35,000 restricted stock units on February 27, 2025.

Summary

  • Mark Hopman, the Chief Commercial Officer of Beta Bionics, Inc., was granted 35,000 shares of common stock as a restricted stock unit award on February 27, 2025.
  • He also received an option to purchase 52,000 shares of common stock at an exercise price of $19.91 per share.
  • The stock options vest in 36 equal monthly installments starting from February 27, 2025, and expire on February 26, 2035.
  • Following these transactions, Hopman directly owns 35,000 shares of common stock and options to purchase 52,000 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options and restricted stock units is a standard practice and generally viewed as a positive sign of aligning management interests with shareholders.

Positives

  • The grant of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
  • The vesting schedule of the options encourages long-term commitment from the executive.

Industry Context

Stock option and restricted stock unit grants are common practices in the biotechnology industry to incentivize executives and align their interests with the long-term success of the company. These grants are designed to attract and retain top talent in a competitive market.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages in the biotech industry.
  • Companies like Insulet and Dexcom also use stock options and restricted stock units to incentivize their executives.
  • The vesting schedule of 36 months is a typical vesting period for stock options in the industry.

Stakeholder Impact

  • Shareholders may view the grant of stock options and restricted stock units as a positive sign, aligning management's interests with the company's long-term success.
  • Employees may be motivated by the potential for future stock option grants.

Key Dates

DateDescription
02/27/2025Date of transaction: Grant of restricted stock units and stock options.
02/27/2025Vesting start date for stock options.
02/26/2035Expiration date for stock options.
03/03/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.